Tapewire

NYSE · USD

CI

Cigna Group

Export transactions ↓
Tapewire entity
550
SEC CIK
0001739940
Parsed reports
653

Last 12 months

Inside the activity.

1 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 2026013
Jun 202601
Jul 202600
Aug 202602
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 25, 2019 Filed Nov 27, 2019 00:07 UTC SaleCommon Stock, $.01 Par Value 3,300 $203.70 $672,210.33
Disclosure

SEC source: 0001225208-19-014963 · doc4.xml · nonDerivative · entry 1

PARTRIDGE JOHN · CIK 0001319897 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,180

Read SEC document
November 20, 2019 Filed Nov 21, 2019 22:53 UTC
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,879 $0.00 Strike: $121.14 $0.00
Disclosure

SEC source: 0001225208-19-014751 · doc4.xml · derivative · entry 4

WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 Par Value · 15,879 shares

Expires 2020-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option was granted on March 6, 2013. The option vested in three equal annual installments on February 28, 2014, February 28, 2015 and February 28, 2016.

Read SEC document
November 20, 2019 Filed Nov 21, 2019 22:53 UTC
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
SaleCommon Stock, $.01 Par Value 12,436 $199.15 $2,476,567.22
Disclosure

SEC source: 0001225208-19-014751 · doc4.xml · nonDerivative · entry 2

WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,778

F1 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $199.09 to $199.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
November 20, 2019 Filed Nov 21, 2019 22:53 UTC
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
Exercise / conversionCommon Stock, $.01 Par Value 15,879 $121.14 $1,923,536.01
Disclosure

SEC source: 0001225208-19-014751 · doc4.xml · nonDerivative · entry 1

WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,214

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 20, 2019 Filed Nov 21, 2019 22:52 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
GiftCommon Stock, $.01 Par Value 1,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-014750 · doc4.xml · nonDerivative · entry 1

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,445

Read SEC document
November 19, 2019 Filed Nov 20, 2019 22:44 UTC
Jones Nicole SEVP, General Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,625 $0.00 Strike: $58.73 $0.00
Disclosure

SEC source: 0001225208-19-014724 · doc4.xml · derivative · entry 6

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,582

Underlying: Common Stock, $.01 Par Value · 1,625 shares

Expires 2023-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.

F4 · derivative.exercise_date: This option was granted on March 5, 2013. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
November 19, 2019 Filed Nov 20, 2019 22:44 UTC
Jones Nicole SEVP, General Counsel
Exercise / conversionCommon Stock, $.01 Par Value 1,625 $58.73 $95,436.25
Disclosure

SEC source: 0001225208-19-014724 · doc4.xml · nonDerivative · entry 3

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,073

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.

Read SEC document
November 19, 2019 Filed Nov 21, 2019 22:51 UTC
Sadler Jason DPres., International Markets
SaleCommon Stock, $.01 Par Value 5,500 $198.43 $1,091,366.65
Disclosure

SEC source: 0001225208-19-014749 · doc4.xml · nonDerivative · entry 1

Sadler Jason D · CIK 0001554974 · Pres., International Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,637

F1 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $198.43 to $198.445 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
November 19, 2019 Filed Nov 21, 2019 22:53 UTC
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
GiftCommon Stock, $.01 Par Value 17,894 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-014751 · doc4.xml · nonDerivative · entry 3

WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 24,444

Read SEC document
November 18, 2019 Filed Nov 20, 2019 22:44 UTC
Jones Nicole SEVP, General Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 6,956 $0.00 Strike: $58.73 $0.00
Disclosure

SEC source: 0001225208-19-014724 · doc4.xml · derivative · entry 5

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,207

Underlying: Common Stock, $.01 Par Value · 6,956 shares

Expires 2023-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.

F4 · derivative.exercise_date: This option was granted on March 5, 2013. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 22:44 UTC
Jones Nicole SEVP, General Counsel
SaleCommon Stock, $.01 Par Value 6,956 $200.58 $1,395,208.74
Disclosure

SEC source: 0001225208-19-014724 · doc4.xml · nonDerivative · entry 2

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,448

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.

F2 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $200.30 to $201.065 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 22:44 UTC
Jones Nicole SEVP, General Counsel
Exercise / conversionCommon Stock, $.01 Par Value 6,956 $58.73 $408,525.88
Disclosure

SEC source: 0001225208-19-014724 · doc4.xml · nonDerivative · entry 1

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,404

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018.

Read SEC document
November 12, 2019 Filed Nov 14, 2019 22:36 UTC
Manders Matthew GPresident, Strategy & Solution
GiftCommon Stock, $.01 Par Value 1,605 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-014503 · doc4.xml · nonDerivative · entry 1

Manders Matthew G · CIK 0001480601 · President, Strategy & Solution

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,488

Read SEC document
September 13, 2019 Filed Sep 17, 2019 17:37 UTC SaleCommon Stock, $.01 Par Value 308 $160.10 $49,310.80
Disclosure

SEC source: 0001225208-19-012644 · doc4.xml · nonDerivative · entry 1

ZOLLARS WILLIAM D · CIK 0001085324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,500

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2019.

F2 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
September 09, 2019 Filed Sep 9, 2019 18:01 UTC
Cordani DavidDirector · President & CEO
PurchaseCommon Stock, $.01 Par Value 32,509 $155.17 $5,044,421.53
Disclosure

SEC source: 0001225208-19-012228 · doc4.xml · nonDerivative · entry 1

Cordani David · CIK 0001318751 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,914

Read SEC document
August 30, 2019 Filed Sep 4, 2019 17:34 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012171 · doc4.xml · nonDerivative · entry 1

ROPER WILLIAM L · CIK 0001087960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,127

Read SEC document
August 30, 2019 Filed Sep 4, 2019 17:34 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012173 · doc4.xml · nonDerivative · entry 1

ZOLLARS WILLIAM D · CIK 0001085324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,808

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012172 · doc4.xml · nonDerivative · entry 1

ZARCONE DONNA F · CIK 0001243083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,563

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC GrantPhantom Stock Units · Derivative 175 $153.97 $26,944.75
Disclosure

SEC source: 0001225208-19-012170 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,660

Underlying: Common Stock, $.01 Par Value · 175 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012170 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,150

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012169 · doc4.xml · nonDerivative · entry 1

PARTRIDGE JOHN · CIK 0001319897 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,480

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012168 · doc4.xml · nonDerivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,101

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012167 · doc4.xml · nonDerivative · entry 1

MAZZARELLA KATHLEEN M · CIK 0001273233 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,101

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012166 · doc4.xml · nonDerivative · entry 1

MARTINEZ ROMAN IV · CIK 0001276303 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,609

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC
HARRIS ISAIAH JRDirector · Chairman of the Board
GrantCommon Stock, $.01 Par Value 373 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012165 · doc4.xml · nonDerivative · entry 1

HARRIS ISAIAH JR · CIK 0001202287 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,460

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012164 · doc4.xml · nonDerivative · entry 1

Granger Elder · CIK 0001625579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,623

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:34 UTC
FOSS ERIC JDirector
GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012163 · doc4.xml · nonDerivative · entry 1

FOSS ERIC J · CIK 0001197007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,246

Read SEC document
August 30, 2019 Filed Sep 4, 2019 21:33 UTC GrantCommon Stock, $.01 Par Value 308 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-012162 · doc4.xml · nonDerivative · entry 1

DeLaney William J III · CIK 0001384151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,883

Read SEC document
August 16, 2019 Filed Aug 20, 2019 17:27 UTC SaleCommon Stock, $.01 Par Value 320 $160.33 $51,305.60
Disclosure

SEC source: 0001225208-19-011757 · doc4.xml · nonDerivative · entry 1

ZOLLARS WILLIAM D · CIK 0001085324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,500

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2019.

F2 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
May 31, 2019 Filed Jun 3, 2019 18:23 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008744 · doc4.xml · nonDerivative · entry 3

ROPER WILLIAM L · CIK 0001087960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,819

Read SEC document
May 31, 2019 Filed Jun 4, 2019 17:14 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008815 · doc4.xml · nonDerivative · entry 1

ZOLLARS WILLIAM D · CIK 0001085324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,820

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:14 UTC GrantPhantom Stock Units · Derivative 183 $148.02 $27,087.66
Disclosure

SEC source: 0001225208-19-008816 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,485

Underlying: Common Stock, $.01 Par Value · 183 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F2 · balance_after: Includes 3 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferred Compensation Plan for Directors of Cigna Corporation.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:14 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008816 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,842

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:14 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008814 · doc4.xml · nonDerivative · entry 1

ZARCONE DONNA F · CIK 0001243083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,255

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:14 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008813 · doc4.xml · nonDerivative · entry 1

PARTRIDGE JOHN · CIK 0001319897 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,172

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:14 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008812 · doc4.xml · nonDerivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 793

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:14 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008811 · doc4.xml · nonDerivative · entry 1

MAZZARELLA KATHLEEN M · CIK 0001273233 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 793

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:14 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008810 · doc4.xml · nonDerivative · entry 1

MARTINEZ ROMAN IV · CIK 0001276303 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,301

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:13 UTC
HARRIS ISAIAH JRDirector · Chairman of the Board
GrantCommon Stock, $.01 Par Value 388 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008809 · doc4.xml · nonDerivative · entry 1

HARRIS ISAIAH JR · CIK 0001202287 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,087

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:13 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008808 · doc4.xml · nonDerivative · entry 1

Granger Elder · CIK 0001625579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,315

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:13 UTC
FOSS ERIC JDirector
GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008807 · doc4.xml · nonDerivative · entry 1

FOSS ERIC J · CIK 0001197007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,938

Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:13 UTC GrantCommon Stock, $.01 Par Value 320 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008806 · doc4.xml · nonDerivative · entry 1

DeLaney William J III · CIK 0001384151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,575

Read SEC document
May 30, 2019 Filed Jun 3, 2019 18:23 UTC Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 3,298 $0.00 Strike: $109.39 $0.00
Disclosure

SEC source: 0001225208-19-008744 · doc4.xml · derivative · entry 5

ROPER WILLIAM L · CIK 0001087960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 Par Value · 3,298 shares

Expires 2019-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents options that were automatically exercised immediately prior to their expiration.

F3 · derivative.exercise_date: Stock options previously awarded pursuant to Express Scripts, Inc. 2011 Long-Term Incentive Plan. Options vested in three equal annual installments on May 1, 2013, May 1, 2014, and May 1, 2015.

Read SEC document
May 30, 2019 Filed Jun 3, 2019 18:23 UTC Tax withholdingCommon Stock, $.01 Par Value 2,438 $147.99 $360,799.62
Disclosure

SEC source: 0001225208-19-008744 · doc4.xml · nonDerivative · entry 2

ROPER WILLIAM L · CIK 0001087960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,499

F1 · shares: Represents shares tendered to Company to cover payment of exercise price due upon exercise of stock options.

Read SEC document
May 30, 2019 Filed Jun 3, 2019 18:23 UTC Exercise / conversionCommon Stock, $.01 Par Value 3,298 $109.39 $360,774.82
Disclosure

SEC source: 0001225208-19-008744 · doc4.xml · nonDerivative · entry 1

ROPER WILLIAM L · CIK 0001087960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,937

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2019 Filed May 7, 2019 21:39 UTC
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
Tax withholdingCommon Stock, $.01 Par Value 1,658 $152.83 $253,392.14
Disclosure

SEC source: 0001567619-19-010048 · doc1.xml · nonDerivative · entry 1

WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,335

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 21:16 UTC Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 2,199 $0.00 Strike: $109.39 $0.00
Disclosure

SEC source: 0001225208-19-005536 · doc4.xml · derivative · entry 2

DeLaney William J III · CIK 0001384151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 Par Value · 2,199 shares

Expires 2019-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Stock option previously awarded pursuant to Express Scripts, Inc. 2011 Long-Term Incentive Plan. Options vested in three equal annual installments on May 1, 2013, May 1, 2014, and May 1, 2015.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 21:16 UTC Exercise / conversionCommon Stock, $.01 Par Value 2,199 $109.39 $240,553.01
Disclosure

SEC source: 0001225208-19-005536 · doc4.xml · nonDerivative · entry 1

DeLaney William J III · CIK 0001384151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,255

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 17:11 UTC SaleCommon Stock, $.01 Par Value 272 $168.43 $45,812.50
Disclosure

SEC source: 0001225208-19-005374 · doc4.xml · nonDerivative · entry 1

ZOLLARS WILLIAM D · CIK 0001085324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,500

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
March 11, 2019 Filed Mar 13, 2019 21:45 UTC
Evanko Brian CPresident Government Business
PurchaseCommon Stock, $.01 Par Value 2,000 $163.40 $326,800.00
Disclosure

SEC source: 0001225208-19-005235 · doc4.xml · nonDerivative · entry 1

Evanko Brian C · CIK 0001722909 · President Government Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,563

F1 · price: Represents the weighted average price of the shares purchased. The prices actually paid ranged from $163.38 to $163.40 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.